EurekaMag.com logo
+ Translate

Paecilomyces varioti peritonitis in patients on continuous ambulatory peritoneal dialysis


, : Paecilomyces varioti peritonitis in patients on continuous ambulatory peritoneal dialysis. American Journal of Kidney Diseases 27(1): 138-142

Paecilomyces varioti infection is a rare cause of peritonitis in patients on continuous ambulatory peritoneal dialysis (CAPD). We report two patients who developed P varioti peritonitis complicating CAPD. The clinical features and microbiological data of seven other previously reported cases are reviewed. Approximately half of the patients had received multiple antibiotics before the onset of the peritonitis because of either bacterial peritonitis or exit site infection. There was no particular pattern of peritoneal dialysate cell count, which was characteristic in this fungal peritonitis. Although all patients survived, morbidity was high. All patients required antifungal chemotherapy and removal of peritoneal catheter for eradication of the organism. Amphotericin B was effective in most cases. Patients of all previously reported cases did not go back to peritoneal dialysis after removal of peritoneal catheters. A combination of oral flucytosine and itraconazole was successful in treating our two patients. Although we managed to resume CAPD in our two patients with good functional outcome, abscesses and adhesions were major problems rendering most patients from other series failing to return to CAPD after recovery.

(PDF 0-2 workdays service)

Accession: 046907507

PMID: 8546129

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Kovac, D.; Lindic, J.; Lejko-Zupanc, T.; Bren, A.F.; Knap, B.; Lesnik, M.; Gucek, A.; Ferluga, D., 1998: Treatment of severe Paecilomyces varioti peritonitis in a patient on continuous ambulatory peritoneal dialysis. Nephrology, Dialysis, Transplantation 13(11): 2943-2946

Mandarapu, S.B.; Mukku, K.K.; Raju, S.B.; Chandragiri, S., 2015: Successful catheter reinsertion in a case of Paecilomyces varioti peritonitis in a patient on continuous ambulatory peritoneal dialysis. Peritonitis is one of the most common and important complications in patients on continuous ambulatory peritoneal dialysis (CAPD). Fungal peritonitis isreported in 4-8% of peritonitis episodes. Fungal peritonitis due to Paecilomyces species is not...

Chan, T.H.; Koehler, A.; Li, P.K.T., 1996: Paecilomyces variotii peritonitis in patients on continuous ambulatory peritoneal dialysis. Cases are reported in 2 patients (44- and 60-yr-old women) from Hong Kong who developed P. variotii peritonitis complicating continuous ambulatory peritoneal dialysis (CAPD). Both patients were treated with antifungal therapy (flucytosine and itra...

Lye, W.C., 1990: Paecilomyces peritonitis in a patient on continuous ambulatory peritoneal dialysis. Nephrology, Dialysis, Transplantation 5(12): 1053-1054

Eisinger, R.P.; Weinstein, M.P., 1991: A bold mold? Paecilomyces variotii peritonitis during continuous ambulatory peritoneal dialysis. A patient on peritoneal dialysis developed peritonitis due to Paecilomyces variotii. It appears that this relatively rare organism may be starting to assert itself as a more important human pathogen. A plea is made for speciation.

Eisinger, R.P.; Weinstein, M.P., 1991: A bold mold? Paecilomyces variotii peritonitis during continuous ambulatory peritoneal dialysis. A patient on peritoneal dialysis developed peritonitis due to Paecilomyces variotii. It appears that this relatively rare organism may be starting to assert itself as a more important human pathogen. A plea is made for speciation.

Von Lilien T.; Salusky I.B.; Alliapoulos J.C.; Leichter H.E.; Wilson M.; Hall T.L.; Fine R.N., 1985: The effect of chronic continuous ambulatory peritoneal dialysis and continuous cyclic peritoneal dialysis treatment and peritonitis on peritoneal clearances in pediatric patients. Pediatric Research 19(4 PART 2): 385A

Mars, R.L.; Moles, K.; Pope, K.; Hargrove, P., 2000: Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis. Peritonitis is the most common complication of peritoneal dialysis (PD) and accounts for the most drop-out from PD among patients with end-stage renal disease (ESRD). Antibiotic protocols to treat peritonitis recommend initial treatment for both g...

Von Lilien T.; Salusky I.B.; Alliapolous J.C.; Leichter H.E.; Wilson M.; Hall T.L.; Fine R.N., 1986: Effect of long term continuous ambulatory peritoneal dialysis continuous cyclic peritoneal dialysis and peritonitis on the peritoneal membrane function and peritoneal kinetics in children. Kidney International 29(1): 238

Griveas, I.; Fleva, A.; Karanikas, E.; Gogos, K.; Sakellariou, G., 2010: CD4/CD8 T-cell ratio in peritoneal dialysis effluents predicts the outcome of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. This study aimed to clarify the role of peritoneal T-lymphocytes in peritoneal immune defense mechanisms. This study was designed to examine the changes in T-cell subpopulations during peritonitis in patients treated with continuous ambulatory per...